Litcius/Paper detail

Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial

Daniel J. Goldstein, Helena Chang, Michael J. Mack, Pierre Voisine, James S. Gammie, Mary E. Marks, Alexander Iribarne, Yuliya Vengrenyuk, Samantha Raymond, Bradley Taylor, François Dagenais, Gorav Ailawadi, Michael Chu, J. Michael DiMaio, Jagat Narula, Ellen Moquete, Karen O’Sullivan, Judson B. Williams, Juan A. Crestanello, Vincent Scavo, John D. Puskas, Michael A. Acker, Marc Gillinov, Annetine C. Gelijns, Patrick T. O’Gara, Alan J. Moskowitz, John H. Alexander, Emilia Bagiella

2022Journal of Thoracic and Cardiovascular Surgery19 citationsDOIOpen Access PDF

Topics & Concepts

VESTMedicineIntimal hyperplasiaRandomized controlled trialSaphenous vein graftVeinInternal medicineDiseaseSurgeryClinical trialHyperplasiaCardiologySmooth muscleArteryStatisticsMathematicsCoronary Interventions and DiagnosticsCardiac and Coronary Surgery TechniquesAtrial Fibrillation Management and Outcomes
Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial | Litcius